These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35743495)

  • 1. Impact of Continuous Flow Left Ventricular Assist Device on Heart Transplant Candidates: A Multi-State Survival Analysis.
    Carrozzini M; Bottio T; Caraffa R; Bejko J; Bifulco O; Guariento A; Lombardi CM; Metra M; Azzolina D; Gregori D; Fedrigo M; Castellani C; Tarzia V; Toscano G; Gambino A; Jorgji V; Ferrari E; Angelini A; Gerosa G
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of left ventricular assist device therapy as bridge to transplant in an Asian city with scarce heart transplant donor.
    Wong KL; Ho KLC; Lee OJ; Lun KS; Bhatia I; Tam WYE; Fan YYK; Au WKT
    J Thorac Dis; 2021 Oct; 13(10):5717-5730. PubMed ID: 34795921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support.
    Han J; Moayedi Y; Yang W; Henricksen EJ; Lee R; Purewal S; Chang E; Duclos S; Lyapin A; Feng K; Hiesinger W; Teuteberg JJ; Khush KK
    J Heart Lung Transplant; 2022 Feb; 41(2):237-243. PubMed ID: 34815161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after heart transplantation in patients who have undergone a bridge-to-bridge strategy.
    Zhou AL; Etchill EW; Shou BL; Whitbread JJ; Barbur I; Giuliano KA; Kilic A
    JTCVS Open; 2022 Dec; 12():255-268. PubMed ID: 36590736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study.
    Tenge T; Roth S; M'Pembele R; Lurati Buse G; Boenner F; Ballázs C; Tudorache I; Boeken U; Lichtenberg A; Neukirchen M; Huhn R; Aubin H
    Life (Basel); 2022 Nov; 12(12):. PubMed ID: 36556331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Kitada S; Schulze PC; Jin Z; Clerkin K; Homma S; Mancini DM
    Int J Cardiol; 2016 Jan; 203():929-935. PubMed ID: 26618255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
    Ammirati E; Brambatti M; Braun OÖ; Shah P; Cipriani M; Bui QM; Veenis J; Lee E; Xu R; Hong KN; Van de Heyning CM; Perna E; Timmermans P; Cikes M; Brugts JJ; Veronese G; Minto J; Smith S; Gjesdal G; Gernhofer YK; Partida C; Potena L; Masetti M; Boschi S; Loforte A; Jakus N; Milicic D; Nilsson J; De Bock D; Sterken C; Van den Bossche K; Rega F; Tran H; Singh R; Montomoli J; Mondino M; Greenberg B; Russo CF; Pretorius V; Liviu K; Frigerio M; Adler ED
    Int J Cardiol; 2021 Feb; 324():122-130. PubMed ID: 32950592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right and left ventricular assist devices are an option for bridge to heart transplant.
    Barac YD; Toledano R; Jawitz OK; Schroder JN; Daneshmand MA; Patel CB; Aravot D; Milano CA
    JTCVS Open; 2022 Mar; 9():146-159. PubMed ID: 36003474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.